86 results
8-K
EX-99.1
ICU
SeaStar Medical Holding Corp
14 May 24
SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
4:05pm
for the treatment of pediatric patients with acute kidney injury (AKI) and sepsis or septic condition. Quelimmune has the potential to save lives … commercial and development programs, and corporate activities:
Pediatric Acute Kidney Injury
Only about half of patients in the pediatric ICU with AKI who
8-K
EX-99.1
ICU
SeaStar Medical Holding Corp
17 Apr 24
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
4:01pm
suffering from acute kidney injury (AKI) and sepsis. We are proud to be the only company to develop and commercialize a therapeutic device that’s … .”
SeaStar Medical provides the following updates on its commercial and development programs, and corporate activities:
Pediatric Acute Kidney Injury
8-K/A
EX-99.1
ICU
SeaStar Medical Holding Corp
27 Mar 24
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
5:23pm
pivotal adult acute kidney injury (AKI) study with 23 subjects enrolled, including two additional subjects since our last update two weeks ago … , New Therapies in Pediatric Acute Kidney Injury, held at the AKI-CRRT 2024 conference earlier this month, with key opinion leaders from our
8-K
EX-99.1
mgnjnzv dptov4
27 Mar 24
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
8:32am
424B3
gso0h9agjw
5 Mar 24
Prospectus supplement
5:08pm
424B3
ix1rrsne0m9 3ay07ypz
5 Mar 24
Prospectus supplement
4:59pm
424B3
42g01maklcrckoscn1v
5 Mar 24
Prospectus supplement
4:57pm
424B3
f5j x92bj6i
5 Mar 24
Prospectus supplement
4:56pm
8-K
EX-99.1
tmc43k ng
22 Feb 24
FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury
8:00am
8-K
s81lye sssfgpu9ya8
22 Feb 24
FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury
8:00am
424B5
oie9ri3j5y
30 Jan 24
Prospectus supplement for primary offering
10:55am
S-3
k6ddem4tzog
1 Dec 23
Shelf registration
4:06pm
8-K
EX-99.1
zqug7800qchd6c
21 Nov 23
SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update
6:04pm